O'Toole David D
CFO
O'Toole David D has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 8 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, O'Toole David D is listed as CFO at AVITA Medical, Inc. Inside the rolling window, O'Toole David D reported 5 open-market purchases totaling $46K in RCEL and no open-market sales. The largest disclosed transaction in the window is a purchase of 3,000 RCEL shares on Feb 19, 2026, worth $12K.
Companies traded
Other insiders at RCEL
Insider Buying
$46K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has O'Toole David D made?
O'Toole David D has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does O'Toole David D trade?
O'Toole David D has filed SEC Form 4 disclosures for 1 company, including RCEL.
When was O'Toole David D's most recent SEC Form 4 filing?
O'Toole David D's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is O'Toole David D's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, O'Toole David D is listed as CFO.
What is O'Toole David D's total buy and sell value in the current window?
Inside the rolling retention window, O'Toole David D bought $46K and sold $0 based on SEC Form 4 filings.
What was O'Toole David D's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,000 RCEL shares on 2026-02-19, worth $12K, per SEC Form 4 filings.